Petros Pharmaceuticals (PTPI)
NASDAQ:PTPI
US Market
Holding PTPI?
Track your performance easily

Petros Pharmaceuticals (PTPI) Financial Statements

107 Followers

Petros Pharmaceuticals Financial Overview

Petros Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-6.205; its P/E ratio is -0.05; Petros Pharmaceuticals is scheduled to report earnings on November 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 1.42M$ 1.39M$ 1.67M$ 1.99M$ 2.52M
Gross Profit$ 1.09M$ 1.06M$ 1.27M$ 1.48M$ 1.97M
EBIT$ -781.42K$ -3.58M$ -4.42M$ -2.60M$ -3.83M
EBITDA$ -26.75K$ -2.83M$ -3.59M$ -1.74M$ -2.97M
Net Income Common Stockholders$ -2.73M$ -8.03M$ -4.89M$ -2.55M$ -1.39M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.46M$ 11.08M$ 17.97M$ 7.38M$ 8.32M
Total Assets$ 25.17M$ 30.31M$ 38.91M$ 28.73M$ 30.57M
Total Debt$ 7.63M$ 8.01M$ 8.39M$ 8.76M$ 9.12M
Net Debt$ 174.11K$ -3.07M$ -9.58M$ 1.37M$ 799.87K
Total Liabilities$ 15.98M$ 19.62M$ 31.86M$ 15.78M$ 15.12M
Stockholders Equity$ 8.07M$ 9.79M$ 6.93M$ 12.94M$ 15.45M
Cash Flow-
Free Cash Flow$ -1.66M$ -1.13M$ -4.05M$ -572.07K$ -748.36K
Operating Cash Flow$ -1.66M$ -1.13M$ -4.05M$ -572.07K$ -748.36K
Investing Cash Flow-----
Financing Cash Flow$ -1.96M$ -1.12M$ 14.63M$ -363.20K$ -357.83K
Currency in USD

Petros Pharmaceuticals Earnings and Revenue History

Petros Pharmaceuticals Debt to Assets

Petros Pharmaceuticals Cash Flow

Petros Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis